Philip Lee
Vorstandsvorsitzender bei GeneFab LLC
Vermögen: 261 262 $ am 30.04.2024
Profil
Philip Lee was the founder of Senti Sub I, Inc. (founded in 2016), Cellasic Corp.
(founded in 2004), and Senti Biosciences, Inc. (founded in 2016) where he held the titles of Chief Operating Officer, Chief Executive Officer, and Chief Technology Officer respectively.
Currently, he is the Chief Executive Officer at GeneFab LLC since 2023.
Previously, he worked as Head-Cell Culture Systems at EMD Millipore Corp.
and Merck KGaA from 2012 to 2016.
Dr. Lee received his undergraduate degree from Massachusetts Institute of Technology and doctorate degrees from the University of California, Berkeley and the University of California, San Francisco.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SENTI BIOSCIENCES, INC.
2,05% | 01.02.2023 | 936 424 ( 2,05% ) | 261 262 $ | 30.04.2024 |
Aktive Positionen von Philip Lee
| Unternehmen | Position | Beginn |
|---|---|---|
GeneFab LLC
 GeneFab LLC BiotechnologyHealth Technology GeneFab LLC develops and commercializes genetic medicines. The American company was founded in 2023 and the CEO is Philip Lee. | Vorstandsvorsitzender | 01.08.2023 |
Ehemalige bekannte Positionen von Philip Lee
| Unternehmen | Position | Ende |
|---|---|---|
| SENTI BIOSCIENCES, INC. | Gründer | 07.08.2023 |
| MERCK KGAA | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2014 |
EMD Millipore Corp.
 EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2014 |
Cellasic Corp.
 Cellasic Corp. Packaged SoftwareTechnology Services Cellasic Corp. develops a microfluidic software platform for live cell analysis experiments. The American company was founded by Philip Lee. | Vorstandsvorsitzender | 01.04.2012 |
Senti Sub I, Inc.
 Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Gründer | - |
Ausbildung von Philip Lee
| Massachusetts Institute of Technology | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
| The University of California, San Francisco | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MERCK KGAA | Health Technology |
| SENTI BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
EMD Millipore Corp.
EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Commercial Services |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Health Technology |
Cellasic Corp.
Cellasic Corp. Packaged SoftwareTechnology Services Cellasic Corp. develops a microfluidic software platform for live cell analysis experiments. The American company was founded by Philip Lee. | Technology Services |
GeneFab LLC
GeneFab LLC BiotechnologyHealth Technology GeneFab LLC develops and commercializes genetic medicines. The American company was founded in 2023 and the CEO is Philip Lee. | Health Technology |
